跳至主要内容
临床试验/ACTRN12610000077066
ACTRN12610000077066已完成未知

Prospective, Randomized, Follow up Study of the St. Jude Medical identity AFx DR to determine whether or not the reduction of Atrial Fibrillation (AF) by the AF suppression algorithm halts or reverses electrical remodeling that has already begun in AF patients

St. Jude Medical0 个研究点目标入组 50 人开始时间: 2010年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Patient must have standard indications for a DDD (Dual Chamber) pacemaker
  • - Patient must have documented paroxysmal or persistent Atrial Fibrillation (AF).
  • - Patient must be maintained on a stable antiarrhythmic drug regimen

排除标准

  • - Patient has chronic Atrial Fibrillation
  • - Patient has Class 3 or 4 angina
  • - Patient has an existing Implantable Cardioverter Defibrillator (ICD) or is being considered for an ICD implant.
  • - Patients life expectancy is less than 6 months due to other medical conditions
  • - Patient has a serious comorbid condition (i.e. metastaic disease, chronic renal failure etc)

研究者

相似试验